Striatal neurones receive myriad of synaptic inputs originating from differ
ent sources. Massive afferents from all areas of the cortex and the thalamu
s represent the most important source of excitatory amino acids, whereas th
e nigrostriatal pathway and intrinsic circuits provide the striatum with do
pamine, acetylcholine, GABA, nitric oxide and adenosine. All these neurotra
nsmitter systems interact each other and with voltage-dependent conductance
s to regulate the efficacy of the synaptic transmission within this nucleus
. The integrative action exerted by striatal projection neurones on this co
nverging information dictates the final output of the striatum to the other
basal ganglia structures. Recent morphological, immunohistochemical and el
ectrophysiological findings demonstrated that the striatum also contains di
fferent interneurones, whose role in physiological and pathological conditi
ons represents an intriguing challenge in these years. The use of the in vi
tro brain slice preparation has allowed not only the detailed investigation
of the direct pre- and postsynaptic electrophysiological actions of severa
l neurotransmitters in striatal neurones, but also the understanding of the
ir role in two different forms of corticostriatal synaptic plasticity, long
-term depression and long-term potentiation. These long-lasting changes in
the efficacy of excitatory transmission have been proposed to represent the
cellular basis of some fc,rms of motor learning and are altered in animal
models of human basal ganglia disorders, such as Parkinson's disease. The s
triatum also expresses high sensitivity to hypoxic-aglycemic insults. Durin
g these pathological conditions, striatal synaptic transmission is altered
depending on presynaptic inhibition of transmitter release and opposite mem
brane potential changes occur in projection neurones and in cholinergic int
erneurones. These ionic mechanisms might partially explain the selective ne
uronal vulnerability observed in the striatum during global ischemia and Hu
ntington's disease. (C) 2000 Elsevier Science Ltd. All rights reserved.